postmenopausal women with osteoporosis treated with prior alendronate or raloxifene. J. Bone Miner.Res. 28, 1328–1336 (2013)
[27]Cosman, F. et al. Effects of intravenous zoledronic acid plus subcutaneous teriparatide [rhPTH(1–34)] in postmenopausal osteoporosis. J. Bone Miner. Res. 26,503–511 (2011).
[28]Cosman, F., Nieves, J. W. & Dempster, D. W. Treatment sequence matters: anabolic and antiresorptive therapy for osteoporosis. J. Bone Miner. Res. 32, 198–202(2017).
[29]Eastell, R. et al. Pharmacological management of osteoporosis in postmenopausal women: an Endocrine Society clinical practice guideline. J. Clin. Endocrinol.Metab. 104, 1595–1622 (2019)
